P-117 Phase II study of combination chemotherapy of gemcitabine/S-1 with nafamostat mesilate for advanced unresectable pancreatic cancer. First report

Benzer Materyaller

• Phase II trial of nafamostat mesilate/gemcitabin/S-1 for unresectable pancreatic cancer.
  Yazar:: Tadashi Uwagawa, ve diğerleri
  Baskı/Yayın Bilgisi: (2022-01-01)
• Phase II trial of nafamostat mesilate/gemcitabin/S-1 for unresectable pancreatic cancer
  Yazar:: Tadashi Uwagawa, ve diğerleri
  Baskı/Yayın Bilgisi: (2022-01-01)
• Radical Resection of a Primarily Unresectable Pancreatic Cancer After Neoadjuvant Chemotherapy Using Gemcitabine, TS-1, and Nafamostat Mesilate; Report of a Case
  Yazar:: Fujiwara, Yuki, ve diğerleri
  Baskı/Yayın Bilgisi: (2015)
• Radical resection of an initially unresectable intrahepatic cholangiocarcinoma after chemotherapy with using gemcitabine, cisplatin, and S-1: report of a case
  Yazar:: Tsunematsu, Masashi, ve diğerleri
  Baskı/Yayın Bilgisi: (2019)
• Radical resection of an initially unresectable intrahepatic cholangiocarcinoma after chemotherapy with using gemcitabine, cisplatin, and S-1: report of a case
  Yazar:: Masashi Tsunematsu, ve diğerleri
  Baskı/Yayın Bilgisi: (2019-06-01)